//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Providing timely news to improve the diagnosis, treatment, and prevention of infectious diseases. Read our coverage: contagionlive.com
Contagion®









Loading...
In our latest podcast, Dr. Nico Michel discusses the cobas MPX-E, a new multiplex blood-screening assay streamlining transfusion safety by enabling simultaneous detection and discrimination of #HIV, #HBV, #HCV, and hepatitis E in a single test. www.contagionlive.com/view/from-pa...
#breaking The HIV treatment combining #islatravir and #lenacapavir achieved its primary efficacy endpoint in two phase 3 trials, bringing the investigational regimen closer to becoming the first approved long-acting oral #HIV therapy. #IDsky www.contagionlive.com/view/once-we...
[email protected] is leveraging its #phage initiative to connect researchers and clinicians, standardize approaches, and explore how phages could complement antibiotics. Dr. Colleen Kraft offers insights on ASM's plans to help grow this modality. #asmmicrobe2026 #IDsky www.contagionlive.com/view/asm-ini...
[email protected] dosed the first participants in LIBERTY, a phase 3 clinical trial evaluating the safety and tolerability of VYD2311, its investigational monoclonal antibody candidate for #COVID-19 prevention. #IDsky #Medsky www.contagionlive.com/view/invivyd...
[email protected] CEO Dr. Stefano Bertuzzi discusses how they are reorganizing its structure to create more focused scientific divisions while maintaining collaboration across disciplines and improving member engagement. #asmmicrobe2026 www.contagionlive.com/view/asm-mic...
Meta-analysis finds approximately 1% of well-appearing outpatient infants aged 60 to 90 days with fever have an invasive bacterial infection. #IDsky #Medsky www.contagionlive.com/view/when-fe...
The #FDA approval of this therapy provides the first approved treatment for chronic #hepatitis delta in the US. Dr Anu Osinusi discusses how this therapy is designed to slow disease progression and improve patient outcomes. #IDsky www.contagionlive.com/view/what-th...
Day 2 in DC! We are conducting more interviews at #ASMmicrobe2026! We are on the second level. Stop by to say hello if you are nearby!
Kelly Oakeson, PhD, explains how Utah public health officials are leveraging a statewide wastewater surveillance system to monitor #measles activity, identify emerging outbreaks, and supplement traditional case reporting. #asmmicrobe2026 www.contagionlive.com/view/wastewa...
Good morning from #ASMMicrobe2026! Look for our coverage over the coming days, and if you see us onsite, please stop by to say hello!
4d
5d
1d
6d
2d
5d
3d
7d
7d
8d
A new multiplex blood-screening assay is streamlining transfusion safety by enabling simultaneous detection and discrimination of HIV, HBV, HCV, and hepatitis E in a single test, helping laboratories ...
www.contagionlive.com
From Pathogen to Infectious Disease Diagnosis: cobas MPX-E adds HEV to NAT screening | Contagion Live
Once-Weekly HIV Pill Meets Phase 3 Endpoints, Advancing Potential First Long-Acting Oral Treatment | Contagion Live
A once-weekly oral HIV treatment combining islatravir and lenacapavir achieved its primary efficacy endpoint in two Phase 3 trials, bringing the investigational regimen closer to becoming the first ap...
www.contagionlive.com
The American Society for Microbiology (ASM) is leveraging its new phage therapy coordination efforts to connect researchers and clinicians, standardize approaches, and explore how bacteriophages could...
www.contagionlive.com
Invivyd has dosed the first participants in LIBERTY, a phase 3 trial comparing VYD2311 to an mRNA COVID vaccine and coadministration, as the BLA-enabling DECLARATION trial completes enrollment.
www.contagionlive.com
ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections | Contagion Live
Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311 | Contagion Live
The FDA's accelerated approval of this therapy provides the first approved treatment option for chronic hepatitis delta in the US. Anu Osinusi, MD, discusses how this targeted therapy is designed to s...
www.contagionlive.com
American Society for Microbiology (ASM) CEO Stefano Bertuzzi, PhD, MPH, discusses how they are reorganizing its structure to create more focused scientific divisions while maintaining collaboration ac...
www.contagionlive.com
What the FDA Approval of Bulevirtide (Hepcludex) Means for Chronic Hepatitis D Treatment | Contagion Live
ASM Microbe Conference: Bringing the Microbiology Community Together | Contagion Live
When Fever in Infants is Invasive Bacterial Infection | Contagion Live
Meta-analysis finds approximately 1% of well-appearing outpatient infants aged 60 to 90 days with fever have an invasive bacterial infection.
www.contagionlive.com
Kelly Oakeson, PhD, explains how Utah public health officials are leveraging a statewide wastewater surveillance system to monitor measles activity, identify emerging outbreaks, and supplement traditi...
www.contagionlive.com
Wastewater Surveillance’s Role in Identifying Measles Outbreaks | Contagion Live
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®